Back to search results

CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Biliary Tract Cancer · Cholangiocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ospedali Riuniti di Ancona, Ancona, Italy

    Contact: Study coordinator (Rossana Berardi)

  • ASST Papa Giovanni XXIII, Bergamo, Italy

    Contact: Study coordinator (Stefania Mosconi)

  • Oncologia Medica Policlinico Sant'Orsola - Malpighi, Bologna, Italy

    Contact: Study coordinator (Giovanni Brandi)

  • ASST Spedali Civili, Brescia, Italy

    Contact: Study coordinator (Giuseppina Arcangeli)

  • Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy

    Contact: Study coordinator (Elena Fea)

  • IRST Dino Amadori, Meldola, Italy

    Contact: Study coordinator (Ilario Giovanni Rapposelli)

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Contact: Study coordinator (Federico Nichetti) · PURITYstudy@istitutotumori.mi.it · 02 2390 3586
    Contact: Study coordinator (Federica Palermo) · federica.palermo@istitutotumori.mi.it · 02 2390 3835
    Federico Nichetti, MD (Sub-investigator)
    Contact: Principal Investigator (Monica Niger, MD)

  • Humanitas Cancer Center, Milan, Italy

    Contact: Study coordinator (Lorenza Rimassa)

  • Ospedale Niguarda Cancer Center, Milan, Italy

    Contact: Study coordinator (Salvatore Siena)

  • Ospedale San Raffaele, Milan, Italy

    Contact: Study coordinator (Andrea Casadei Gardini)

  • Università di Modena, Modena, Italy

    Contact: Study coordinator (Massimilano Salati)

  • Ospedale S. Gerardo, Monza, Italy

    Contact: Study coordinator (Raffaella Longarini)

  • IOV, Padova, Italy

    Contact: Study coordinator (Francesca Bergamo)

  • Policlinico San Matteo, Pavia, Italy

    Contact: Study coordinator (Salvatore Corallo)

  • Azienda Ospedaliera Universitaria Pisa, Pisa, Italy

    Contact: Study coordinator (Lorenzo Fornaro)

  • IRST (Cesena-Forlì-Meldola), Ravenna, Italy

    Contact: Study coordinator (Stefano Tamberi)

  • Policlinico Gemelli, Rome, Italy

    Contact: Study coordinator (Lisa Salvatore)

  • Azienda Ospedaliera Ordine Mauriziano, Turin, Italy

    Contact: Study coordinator (Massimo Di Maio)

  • AOUI Verona - Policlinico "G.B. Rossi", Verona, Italy

    Contact: Study coordinator (Davide Melisi)
Study leads

  • Monica Niger, MD

    Principal Investigator

    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano

  • Monica Niger, MD

    Principal Investigator

    02 2390 2919

View source on ClinicalTrials.gov(opens in a new tab)